nodes	percent_of_prediction	percent_of_DWPC	metapath
Minocycline—CASP3—cervical cancer	0.778	1	CbGaD
Minocycline—CYCS—exocrine gland—cervical cancer	0.00562	0.0532	CbGeAlD
Minocycline—CASP3—exocrine gland—cervical cancer	0.00481	0.0456	CbGeAlD
Minocycline—CASP1—epithelium—cervical cancer	0.00254	0.0241	CbGeAlD
Minocycline—CASP1—uterine cervix—cervical cancer	0.00252	0.0239	CbGeAlD
Minocycline—CYCS—epithelium—cervical cancer	0.00244	0.0232	CbGeAlD
Minocycline—CYCS—uterine cervix—cervical cancer	0.00242	0.023	CbGeAlD
Minocycline—CASP1—decidua—cervical cancer	0.0024	0.0227	CbGeAlD
Minocycline—CASP1—renal system—cervical cancer	0.00236	0.0223	CbGeAlD
Minocycline—CASP1—endometrium—cervical cancer	0.00228	0.0216	CbGeAlD
Minocycline—CYCS—renal system—cervical cancer	0.00227	0.0215	CbGeAlD
Minocycline—CASP1—mammalian vulva—cervical cancer	0.0022	0.0209	CbGeAlD
Minocycline—CASP1—uterus—cervical cancer	0.0021	0.0199	CbGeAlD
Minocycline—CASP3—epithelium—cervical cancer	0.00209	0.0198	CbGeAlD
Minocycline—CASP3—uterine cervix—cervical cancer	0.00208	0.0197	CbGeAlD
Minocycline—CYCS—uterus—cervical cancer	0.00202	0.0191	CbGeAlD
Minocycline—CASP3—decidua—cervical cancer	0.00198	0.0187	CbGeAlD
Minocycline—CASP3—renal system—cervical cancer	0.00194	0.0184	CbGeAlD
Minocycline—CASP1—female reproductive system—cervical cancer	0.00189	0.0179	CbGeAlD
Minocycline—CASP3—endometrium—cervical cancer	0.00188	0.0178	CbGeAlD
Minocycline—CASP3—mammalian vulva—cervical cancer	0.00182	0.0172	CbGeAlD
Minocycline—CYCS—female reproductive system—cervical cancer	0.00182	0.0172	CbGeAlD
Minocycline—CASP3—uterus—cervical cancer	0.00173	0.0164	CbGeAlD
Minocycline—CASP1—female gonad—cervical cancer	0.00172	0.0163	CbGeAlD
Minocycline—CASP1—vagina—cervical cancer	0.00171	0.0162	CbGeAlD
Minocycline—IL1B—epithelium—cervical cancer	0.00167	0.0159	CbGeAlD
Minocycline—CYCS—female gonad—cervical cancer	0.00165	0.0157	CbGeAlD
Minocycline—VEGFA—uterine cervix—cervical cancer	0.00163	0.0155	CbGeAlD
Minocycline—IL1B—decidua—cervical cancer	0.00158	0.015	CbGeAlD
Minocycline—CASP3—female reproductive system—cervical cancer	0.00156	0.0147	CbGeAlD
Minocycline—VEGFA—decidua—cervical cancer	0.00155	0.0147	CbGeAlD
Minocycline—IL1B—renal system—cervical cancer	0.00155	0.0147	CbGeAlD
Minocycline—IL1B—endometrium—cervical cancer	0.0015	0.0142	CbGeAlD
Minocycline—VEGFA—endometrium—cervical cancer	0.00148	0.014	CbGeAlD
Minocycline—VEGFA—mammalian vulva—cervical cancer	0.00143	0.0135	CbGeAlD
Minocycline—CASP3—female gonad—cervical cancer	0.00142	0.0134	CbGeAlD
Minocycline—CASP3—vagina—cervical cancer	0.00141	0.0133	CbGeAlD
Minocycline—MMP9—epithelium—cervical cancer	0.00139	0.0132	CbGeAlD
Minocycline—IL1B—uterus—cervical cancer	0.00138	0.0131	CbGeAlD
Minocycline—MMP9—uterine cervix—cervical cancer	0.00138	0.0131	CbGeAlD
Minocycline—VEGFA—uterus—cervical cancer	0.00136	0.0129	CbGeAlD
Minocycline—MMP9—decidua—cervical cancer	0.00132	0.0125	CbGeAlD
Minocycline—MMP9—renal system—cervical cancer	0.00129	0.0123	CbGeAlD
Minocycline—MMP9—endometrium—cervical cancer	0.00125	0.0118	CbGeAlD
Minocycline—IL1B—female reproductive system—cervical cancer	0.00124	0.0118	CbGeAlD
Minocycline—SLC22A11—renal system—cervical cancer	0.00123	0.0116	CbGeAlD
Minocycline—SLC22A7—renal system—cervical cancer	0.0012	0.0113	CbGeAlD
Minocycline—MMP9—uterus—cervical cancer	0.00115	0.0109	CbGeAlD
Minocycline—IL1B—female gonad—cervical cancer	0.00113	0.0107	CbGeAlD
Minocycline—IL1B—vagina—cervical cancer	0.00112	0.0106	CbGeAlD
Minocycline—VEGFA—female gonad—cervical cancer	0.00111	0.0105	CbGeAlD
Minocycline—VEGFA—vagina—cervical cancer	0.00111	0.0105	CbGeAlD
Minocycline—CASP1—lymph node—cervical cancer	0.0011	0.0105	CbGeAlD
Minocycline—CYCS—lymph node—cervical cancer	0.00106	0.0101	CbGeAlD
Minocycline—ALOX5—decidua—cervical cancer	0.00104	0.00987	CbGeAlD
Minocycline—MMP9—female reproductive system—cervical cancer	0.00104	0.00981	CbGeAlD
Minocycline—SLC22A11—female reproductive system—cervical cancer	0.000982	0.0093	CbGeAlD
Minocycline—MMP9—female gonad—cervical cancer	0.000942	0.00893	CbGeAlD
Minocycline—CASP3—lymph node—cervical cancer	0.00091	0.00862	CbGeAlD
Minocycline—ALOX5—female reproductive system—cervical cancer	0.000819	0.00776	CbGeAlD
Minocycline—ALOX5—female gonad—cervical cancer	0.000745	0.00706	CbGeAlD
Minocycline—IL1B—lymph node—cervical cancer	0.000727	0.00689	CbGeAlD
Minocycline—VEGFA—lymph node—cervical cancer	0.000715	0.00678	CbGeAlD
Minocycline—SLC22A8—renal system—cervical cancer	0.000691	0.00655	CbGeAlD
Minocycline—MMP9—lymph node—cervical cancer	0.000606	0.00574	CbGeAlD
Minocycline—ALOX5—lymph node—cervical cancer	0.000479	0.00454	CbGeAlD
Minocycline—CASP3—SIDS Susceptibility Pathways—HES1—cervical cancer	0.000294	0.00253	CbGpPWpGaD
Minocycline—MMP9—TWEAK Signaling Pathway—CTNNB1—cervical cancer	0.000293	0.00252	CbGpPWpGaD
Minocycline—CYCS—Apoptosis Modulation and Signaling—CASP3—cervical cancer	0.000292	0.00251	CbGpPWpGaD
Minocycline—VEGFA—Endochondral Ossification—FGFR3—cervical cancer	0.000291	0.0025	CbGpPWpGaD
Minocycline—CYCS—AGE/RAGE pathway—EGFR—cervical cancer	0.000288	0.00248	CbGpPWpGaD
Minocycline—IL1B—Aryl Hydrocarbon Receptor Pathway—EGFR—cervical cancer	0.000281	0.00242	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—HLA-DQB1—cervical cancer	0.000281	0.00242	CbGpPWpGaD
Minocycline—MMP9—AGE/RAGE pathway—CASP8—cervical cancer	0.00028	0.0024	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	0.000278	0.00239	CbGpPWpGaD
Minocycline—CASP1—MAPK Signaling Pathway—CASP8—cervical cancer	0.000276	0.00238	CbGpPWpGaD
Minocycline—IL1B—Leptin signaling pathway—MTOR—cervical cancer	0.000271	0.00233	CbGpPWpGaD
Minocycline—CASP3—Integrated Cancer Pathway—TP53—cervical cancer	0.00027	0.00232	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—GP5—cervical cancer	0.000268	0.00231	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—HES1—cervical cancer	0.000266	0.00229	CbGpPWpGaD
Minocycline—CASP3—Oncostatin M Signaling Pathway—STAT3—cervical cancer	0.000259	0.00223	CbGpPWpGaD
Minocycline—IL1B—Toll-like Receptor Signaling Pathway—CASP8—cervical cancer	0.000257	0.00221	CbGpPWpGaD
Minocycline—VEGFA—Bladder Cancer—EGFR—cervical cancer	0.000257	0.00221	CbGpPWpGaD
Minocycline—CASP3—AGE/RAGE pathway—STAT3—cervical cancer	0.000256	0.0022	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—CA9—cervical cancer	0.000252	0.00217	CbGpPWpGaD
Minocycline—CYCS—Apoptosis—CASP8—cervical cancer	0.000252	0.00217	CbGpPWpGaD
Minocycline—VEGFA—Integrins in angiogenesis—CASP8—cervical cancer	0.000252	0.00217	CbGpPWpGaD
Minocycline—IL1B—IL12-mediated signaling events—STAT3—cervical cancer	0.00025	0.00215	CbGpPWpGaD
Minocycline—CASP1—Signaling by Interleukins—STAT3—cervical cancer	0.00025	0.00215	CbGpPWpGaD
Minocycline—VEGFA—Heart Development—CTNNB1—cervical cancer	0.000245	0.00211	CbGpPWpGaD
Minocycline—IL1B—Allograft Rejection—CASP3—cervical cancer	0.000239	0.00205	CbGpPWpGaD
Minocycline—IL1B—Alzheimers Disease—CASP3—cervical cancer	0.000239	0.00205	CbGpPWpGaD
Minocycline—CASP3—LPA receptor mediated events—EGFR—cervical cancer	0.000239	0.00205	CbGpPWpGaD
Minocycline—CASP3—Copper homeostasis—TP53—cervical cancer	0.000236	0.00203	CbGpPWpGaD
Minocycline—CYCS—DNA Damage Response—TP53—cervical cancer	0.000236	0.00203	CbGpPWpGaD
Minocycline—CYCS—p75(NTR)-mediated signaling—TP53—cervical cancer	0.000234	0.00201	CbGpPWpGaD
Minocycline—IL1B—TCR Signaling Pathway—CD4—cervical cancer	0.000234	0.00201	CbGpPWpGaD
Minocycline—CASP1—Apoptosis—TP53—cervical cancer	0.000233	0.00201	CbGpPWpGaD
Minocycline—CASP3—AGE/RAGE pathway—EGFR—cervical cancer	0.000233	0.002	CbGpPWpGaD
Minocycline—MMP9—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—EGFR—cervical cancer	0.000232	0.00199	CbGpPWpGaD
Minocycline—VEGFA—Signaling events mediated by TCPTP—STAT3—cervical cancer	0.00023	0.00198	CbGpPWpGaD
Minocycline—CYCS—miRNA Regulation of DNA Damage Response—TP53—cervical cancer	0.000228	0.00196	CbGpPWpGaD
Minocycline—CASP3—Corticotropin-releasing hormone—CTNNB1—cervical cancer	0.000225	0.00194	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—HLA-DPB1—cervical cancer	0.000225	0.00194	CbGpPWpGaD
Minocycline—CASP1—Apoptosis Modulation and Signaling—TP53—cervical cancer	0.000219	0.00188	CbGpPWpGaD
Minocycline—MMP9—LPA receptor mediated events—CASP3—cervical cancer	0.000217	0.00187	CbGpPWpGaD
Minocycline—VEGFA—Bladder Cancer—TP53—cervical cancer	0.000216	0.00185	CbGpPWpGaD
Minocycline—MMP9—AGE/RAGE pathway—CASP3—cervical cancer	0.000212	0.00182	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—CASP8—cervical cancer	0.00021	0.00181	CbGpPWpGaD
Minocycline—CYCS—Alzheimers Disease—TP53—cervical cancer	0.00021	0.0018	CbGpPWpGaD
Minocycline—VEGFA—Signaling events mediated by TCPTP—EGFR—cervical cancer	0.000209	0.0018	CbGpPWpGaD
Minocycline—IL1B—Leptin signaling pathway—STAT3—cervical cancer	0.000209	0.0018	CbGpPWpGaD
Minocycline—CASP1—MAPK Signaling Pathway—CASP3—cervical cancer	0.000209	0.0018	CbGpPWpGaD
Minocycline—MMP9—FGF signaling pathway—STAT3—cervical cancer	0.000209	0.0018	CbGpPWpGaD
Minocycline—CASP3—Integrated Breast Cancer Pathway—CASP8—cervical cancer	0.000208	0.00179	CbGpPWpGaD
Minocycline—IL1B—Senescence and Autophagy in Cancer—MTOR—cervical cancer	0.000207	0.00178	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—CASP8—cervical cancer	0.000203	0.00175	CbGpPWpGaD
Minocycline—VEGFA—Oncostatin M Signaling Pathway—MTOR—cervical cancer	0.000202	0.00174	CbGpPWpGaD
Minocycline—IL1B—Regulation of toll-like receptor signaling pathway—CASP8—cervical cancer	0.000201	0.00173	CbGpPWpGaD
Minocycline—CYCS—Apoptosis—TP53—cervical cancer	0.0002	0.00172	CbGpPWpGaD
Minocycline—SLC22A7—Fluoropyrimidine Activity—TP53—cervical cancer	0.000198	0.00171	CbGpPWpGaD
Minocycline—CASP3—Oncostatin M Signaling Pathway—TP53—cervical cancer	0.000198	0.0017	CbGpPWpGaD
Minocycline—CASP1—Immune System—UBE3A—cervical cancer	0.000197	0.00169	CbGpPWpGaD
Minocycline—MMP9—AP-1 transcription factor network—CTNNB1—cervical cancer	0.000195	0.00167	CbGpPWpGaD
Minocycline—CASP3—DNA Damage Response—TP53—cervical cancer	0.000191	0.00164	CbGpPWpGaD
Minocycline—CYCS—Apoptosis—CASP3—cervical cancer	0.000191	0.00164	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—CASP8—cervical cancer	0.000191	0.00164	CbGpPWpGaD
Minocycline—MMP9—CXCR4-mediated signaling events—MTOR—cervical cancer	0.00019	0.00163	CbGpPWpGaD
Minocycline—MMP9—CXCR4-mediated signaling events—CD4—cervical cancer	0.000189	0.00163	CbGpPWpGaD
Minocycline—CASP3—p75(NTR)-mediated signaling—TP53—cervical cancer	0.000189	0.00162	CbGpPWpGaD
Minocycline—CYCS—Apoptosis Modulation and Signaling—TP53—cervical cancer	0.000187	0.00161	CbGpPWpGaD
Minocycline—VEGFA—Aryl Hydrocarbon Receptor—EGFR—cervical cancer	0.000187	0.00161	CbGpPWpGaD
Minocycline—VEGFA—Oncostatin M Signaling Pathway—CASP3—cervical cancer	0.000186	0.0016	CbGpPWpGaD
Minocycline—CASP1—Direct p53 effectors—EGFR—cervical cancer	0.000185	0.00159	CbGpPWpGaD
Minocycline—CASP3—miRNA Regulation of DNA Damage Response—TP53—cervical cancer	0.000184	0.00159	CbGpPWpGaD
Minocycline—CYCS—Apoptosis—CTNNB1—cervical cancer	0.000184	0.00158	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—FGFR3—cervical cancer	0.000178	0.00153	CbGpPWpGaD
Minocycline—MMP9—AGE/RAGE pathway—STAT3—cervical cancer	0.000178	0.00153	CbGpPWpGaD
Minocycline—CASP3—BDNF signaling pathway—MTOR—cervical cancer	0.000178	0.00153	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—HES1—cervical cancer	0.000177	0.00153	CbGpPWpGaD
Minocycline—IL1B—Folate Metabolism—TP53—cervical cancer	0.000177	0.00152	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—HLA-DQB1—cervical cancer	0.000176	0.00151	CbGpPWpGaD
Minocycline—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—cervical cancer	0.000175	0.0015	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—CASP3—cervical cancer	0.000173	0.00149	CbGpPWpGaD
Minocycline—VEGFA—Signaling events mediated by VEGFR1 and VEGFR2—CTNNB1—cervical cancer	0.000173	0.00149	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—CASP8—cervical cancer	0.000173	0.00148	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	0.000172	0.00148	CbGpPWpGaD
Minocycline—CASP3—Integrated Breast Cancer Pathway—MTOR—cervical cancer	0.000171	0.00147	CbGpPWpGaD
Minocycline—CASP3—Alzheimers Disease—TP53—cervical cancer	0.000169	0.00146	CbGpPWpGaD
Minocycline—MMP9—Degradation of the extracellular matrix—CASP3—cervical cancer	0.000167	0.00143	CbGpPWpGaD
Minocycline—MMP9—LPA receptor mediated events—EGFR—cervical cancer	0.000166	0.00142	CbGpPWpGaD
Minocycline—MMP9—AGE/RAGE pathway—EGFR—cervical cancer	0.000162	0.00139	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—TP53—cervical cancer	0.000161	0.00139	CbGpPWpGaD
Minocycline—CASP1—MAPK Signaling Pathway—EGFR—cervical cancer	0.00016	0.00137	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—CASP3—cervical cancer	0.000159	0.00137	CbGpPWpGaD
Minocycline—CASP3—BDNF signaling pathway—CTNNB1—cervical cancer	0.000157	0.00135	CbGpPWpGaD
Minocycline—IL1B—Signaling by Interleukins—STAT3—cervical cancer	0.000156	0.00134	CbGpPWpGaD
Minocycline—VEGFA—Oncostatin M Signaling Pathway—STAT3—cervical cancer	0.000156	0.00134	CbGpPWpGaD
Minocycline—VEGFA—SHP2 signaling—EGFR—cervical cancer	0.000156	0.00134	CbGpPWpGaD
Minocycline—CASP1—Direct p53 effectors—TP53—cervical cancer	0.000155	0.00133	CbGpPWpGaD
Minocycline—IL1B—Alzheimers Disease—TP53—cervical cancer	0.000153	0.00132	CbGpPWpGaD
Minocycline—CASP3—Integrated Breast Cancer Pathway—CTNNB1—cervical cancer	0.000152	0.0013	CbGpPWpGaD
Minocycline—CASP3—Apoptosis Modulation and Signaling—TP53—cervical cancer	0.000151	0.0013	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—CTNNB1—cervical cancer	0.000148	0.00128	CbGpPWpGaD
Minocycline—CASP3—SIDS Susceptibility Pathways—CTNNB1—cervical cancer	0.000148	0.00127	CbGpPWpGaD
Minocycline—MMP9—CXCR4-mediated signaling events—STAT3—cervical cancer	0.000147	0.00126	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—EGFR—cervical cancer	0.000146	0.00126	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—FGFR3—cervical cancer	0.000146	0.00125	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—CASP3—cervical cancer	0.000139	0.00119	CbGpPWpGaD
Minocycline—CASP3—BDNF signaling pathway—STAT3—cervical cancer	0.000137	0.00118	CbGpPWpGaD
Minocycline—VEGFA—VEGFA-VEGFR2 Pathway—MTOR—cervical cancer	0.000136	0.00117	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—MTOR—cervical cancer	0.000135	0.00117	CbGpPWpGaD
Minocycline—CASP1—MAPK Signaling Pathway—TP53—cervical cancer	0.000134	0.00115	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—CTNNB1—cervical cancer	0.000134	0.00115	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—CASP3—cervical cancer	0.000133	0.00114	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—EGFR—cervical cancer	0.000132	0.00114	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—CASP3—cervical cancer	0.000131	0.00112	CbGpPWpGaD
Minocycline—MMP9—AP-1 transcription factor network—TP53—cervical cancer	0.000129	0.00111	CbGpPWpGaD
Minocycline—VEGFA—Signaling by VEGF—MTOR—cervical cancer	0.000128	0.0011	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	0.000126	0.00108	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—MTOR—cervical cancer	0.000125	0.00108	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—CASP8—cervical cancer	0.000125	0.00108	CbGpPWpGaD
Minocycline—CYCS—Metabolism—CA9—cervical cancer	0.000125	0.00107	CbGpPWpGaD
Minocycline—IL1B—Immune System—UBE3A—cervical cancer	0.000123	0.00106	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—TP53—cervical cancer	0.000123	0.00106	CbGpPWpGaD
Minocycline—CYCS—Apoptosis—TP53—cervical cancer	0.000122	0.00105	CbGpPWpGaD
Minocycline—IL1B—Senescence and Autophagy in Cancer—TP53—cervical cancer	0.000122	0.00105	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—FGFR3—cervical cancer	0.00012	0.00104	CbGpPWpGaD
Minocycline—VEGFA—VEGFA-VEGFR2 Pathway—CTNNB1—cervical cancer	0.00012	0.00103	CbGpPWpGaD
Minocycline—CASP3—Integrated Breast Cancer Pathway—EGFR—cervical cancer	0.00012	0.00103	CbGpPWpGaD
Minocycline—VEGFA—Oncostatin M Signaling Pathway—TP53—cervical cancer	0.000119	0.00103	CbGpPWpGaD
Minocycline—CASP1—Immune System—HLA-DPB1—cervical cancer	0.000118	0.00101	CbGpPWpGaD
Minocycline—MMP9—Validated targets of C-MYC transcriptional activation—TP53—cervical cancer	0.000117	0.00101	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—STAT3—cervical cancer	0.000117	0.001	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TAAR6—cervical cancer	0.000114	0.000983	CbGpPWpGaD
Minocycline—VEGFA—Signaling by VEGF—CTNNB1—cervical cancer	0.000114	0.000976	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—TP53—cervical cancer	0.000111	0.000956	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—EGFR—cervical cancer	0.00011	0.000948	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—STAT3—cervical cancer	0.000105	0.0009	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	0.000104	0.000892	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—MTOR—cervical cancer	0.000103	0.000886	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—CASP8—cervical cancer	0.000103	0.000885	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—MTOR—cervical cancer	0.000103	0.000882	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—EGFR—cervical cancer	0.000102	0.000873	CbGpPWpGaD
Minocycline—CASP3—Integrated Breast Cancer Pathway—TP53—cervical cancer	0.000101	0.000867	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—EGFR—cervical cancer	9.98e-05	0.000858	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	9.95e-05	0.000855	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—TP53—cervical cancer	9.87e-05	0.000849	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—STAT3—cervical cancer	9.69e-05	0.000833	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—CASP3—cervical cancer	9.47e-05	0.000815	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—TP53—cervical cancer	9.25e-05	0.000796	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—CASP3—cervical cancer	9.23e-05	0.000794	CbGpPWpGaD
Minocycline—CASP1—Immune System—HLA-DQB1—cervical cancer	9.18e-05	0.00079	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—CTNNB1—cervical cancer	9.13e-05	0.000785	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—WNT2—cervical cancer	8.93e-05	0.000768	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—CTNNB1—cervical cancer	8.9e-05	0.000765	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—EGFR—cervical cancer	8.8e-05	0.000757	CbGpPWpGaD
Minocycline—CASP1—Immune System—CD8A—cervical cancer	8.57e-05	0.000737	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—TP53—cervical cancer	8.52e-05	0.000733	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—MTOR—cervical cancer	8.47e-05	0.000728	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—CD4—cervical cancer	8.45e-05	0.000727	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—TP53—cervical cancer	8.38e-05	0.00072	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	8.35e-05	0.000718	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—HES1—cervical cancer	8.13e-05	0.000699	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—TP53—cervical cancer	7.99e-05	0.000687	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TAAR6—cervical cancer	7.94e-05	0.000683	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—STAT3—cervical cancer	7.92e-05	0.000681	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	7.85e-05	0.000675	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—AKAP13—cervical cancer	7.84e-05	0.000674	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—CA9—cervical cancer	7.7e-05	0.000662	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—CTNNB1—cervical cancer	7.6e-05	0.000653	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	7.57e-05	0.000651	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—CTNNB1—cervical cancer	7.51e-05	0.000646	CbGpPWpGaD
Minocycline—IL1B—Immune System—HLA-DPB1—cervical cancer	7.35e-05	0.000632	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—STAT3—cervical cancer	7.29e-05	0.000627	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—EGFR—cervical cancer	7.23e-05	0.000622	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—EGFR—cervical cancer	7.2e-05	0.000619	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—HES1—cervical cancer	7.05e-05	0.000607	CbGpPWpGaD
Minocycline—CASP1—Immune System—FGFR3—cervical cancer	7.01e-05	0.000603	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—CASP3—cervical cancer	6.98e-05	0.0006	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TAAR6—cervical cancer	6.89e-05	0.000593	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—WNT5A—cervical cancer	6.76e-05	0.000582	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—MTOR—cervical cancer	6.59e-05	0.000567	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—WNT2—cervical cancer	6.2e-05	0.000533	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—NOTCH1—cervical cancer	6.13e-05	0.000528	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—TP53—cervical cancer	6.07e-05	0.000522	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—EGFR—cervical cancer	6.02e-05	0.000518	CbGpPWpGaD
Minocycline—CASP1—Immune System—CASP8—cervical cancer	6e-05	0.000516	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	5.99e-05	0.000516	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—EGFR—cervical cancer	5.95e-05	0.000512	CbGpPWpGaD
Minocycline—IL1B—Immune System—HLA-DQB1—cervical cancer	5.74e-05	0.000493	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—AKAP13—cervical cancer	5.44e-05	0.000468	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—WNT2—cervical cancer	5.38e-05	0.000463	CbGpPWpGaD
Minocycline—IL1B—Immune System—CD8A—cervical cancer	5.36e-05	0.000461	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—NOTCH1—cervical cancer	5.33e-05	0.000458	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—STAT3—cervical cancer	5.09e-05	0.000438	CbGpPWpGaD
Minocycline—CYCS—Metabolism—MTHFR—cervical cancer	5.07e-05	0.000436	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	5.03e-05	0.000433	CbGpPWpGaD
Minocycline—CASP1—Immune System—MTOR—cervical cancer	4.93e-05	0.000424	CbGpPWpGaD
Minocycline—CASP1—Immune System—CD4—cervical cancer	4.92e-05	0.000423	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—NOTCH2—cervical cancer	4.75e-05	0.000408	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—AKAP13—cervical cancer	4.72e-05	0.000406	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—WNT5A—cervical cancer	4.7e-05	0.000404	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—EGFR—cervical cancer	4.52e-05	0.000389	CbGpPWpGaD
Minocycline—IL1B—Immune System—FGFR3—cervical cancer	4.38e-05	0.000377	CbGpPWpGaD
Minocycline—CASP1—Immune System—CTNNB1—cervical cancer	4.37e-05	0.000376	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—WNT5A—cervical cancer	4.08e-05	0.000351	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—CTNNB1—cervical cancer	4.08e-05	0.00035	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—EGFR—cervical cancer	3.93e-05	0.000338	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—HES1—cervical cancer	3.89e-05	0.000335	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—TP53—cervical cancer	3.88e-05	0.000334	CbGpPWpGaD
Minocycline—CASP1—Immune System—STAT3—cervical cancer	3.81e-05	0.000328	CbGpPWpGaD
Minocycline—IL1B—Immune System—CASP8—cervical cancer	3.75e-05	0.000322	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—STAT3—cervical cancer	3.55e-05	0.000306	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—CTNNB1—cervical cancer	3.54e-05	0.000304	CbGpPWpGaD
Minocycline—CASP1—Immune System—EGFR—cervical cancer	3.46e-05	0.000298	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TERT—cervical cancer	3.41e-05	0.000293	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NOTCH2—cervical cancer	3.3e-05	0.000283	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—EGFR—cervical cancer	3.23e-05	0.000278	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—FGFR3—cervical cancer	3.13e-05	0.000269	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—MTHFR—cervical cancer	3.12e-05	0.000269	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—STAT3—cervical cancer	3.08e-05	0.000265	CbGpPWpGaD
Minocycline—IL1B—Immune System—MTOR—cervical cancer	3.08e-05	0.000265	CbGpPWpGaD
Minocycline—IL1B—Immune System—CD4—cervical cancer	3.08e-05	0.000265	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—NOTCH1—cervical cancer	2.94e-05	0.000253	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NOTCH2—cervical cancer	2.86e-05	0.000246	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—EGFR—cervical cancer	2.8e-05	0.000241	CbGpPWpGaD
Minocycline—IL1B—Immune System—CTNNB1—cervical cancer	2.73e-05	0.000235	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—HES1—cervical cancer	2.7e-05	0.000232	CbGpPWpGaD
Minocycline—IL1B—Immune System—STAT3—cervical cancer	2.38e-05	0.000205	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TERT—cervical cancer	2.37e-05	0.000204	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—HES1—cervical cancer	2.35e-05	0.000202	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—TP53—cervical cancer	2.31e-05	0.000199	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—MTOR—cervical cancer	2.2e-05	0.000189	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—FGFR3—cervical cancer	2.17e-05	0.000187	CbGpPWpGaD
Minocycline—IL1B—Immune System—EGFR—cervical cancer	2.17e-05	0.000186	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TERT—cervical cancer	2.06e-05	0.000177	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NOTCH1—cervical cancer	2.04e-05	0.000175	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CTNNB1—cervical cancer	1.95e-05	0.000168	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—FGFR3—cervical cancer	1.89e-05	0.000162	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NOTCH1—cervical cancer	1.77e-05	0.000152	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—STAT3—cervical cancer	1.7e-05	0.000146	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—EGFR—cervical cancer	1.55e-05	0.000133	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—MTOR—cervical cancer	1.53e-05	0.000131	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CASP3—cervical cancer	1.41e-05	0.000121	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CTNNB1—cervical cancer	1.36e-05	0.000117	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MTOR—cervical cancer	1.33e-05	0.000114	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TP53—cervical cancer	1.3e-05	0.000112	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CASP3—cervical cancer	1.22e-05	0.000105	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—STAT3—cervical cancer	1.18e-05	0.000102	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CTNNB1—cervical cancer	1.18e-05	0.000101	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—EGFR—cervical cancer	1.07e-05	9.23e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—STAT3—cervical cancer	1.03e-05	8.82e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—EGFR—cervical cancer	9.32e-06	8.02e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TP53—cervical cancer	9.02e-06	7.75e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TP53—cervical cancer	7.83e-06	6.73e-05	CbGpPWpGaD
